However, further studies that incorporate assessment of serum 25-hydroxyvitamin D status in addition to tumour VDR expression in patients with oesophageal adenocarcinoma are required to corroborate this hypothesis. This evidence concerns the gene VDR and esophageal adenocarcinoma.